Search results for: 'cell ad gene manufacturing'

16 Aug 2022  |  North America  |  Market Research

Global Cell and Gene Therapy (CGT) Growth Opportunities

The Shift to Prevalent Diseases and Allogeneic Cell Therapies Creates New Growth Opportunities in the CGT Value Chain

Infographics

×

This Frost & Sullivan study examines the global cell and gene therapy (CGT) market. It highlights revenue forecasts and key growth opportunities for CGT market participants based on the evolution of their business models and strategic approaches as well as investments and regulations. The study segments the market by product (cell therapy, gene-mod...

16 Aug 2016  |  North America  |  Market Research

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Emerging Business Models Drive Transformation

Infographics

×

The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to comme...

As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...

16 Dec 2022  |  North America  |  Market Research

Growth Opportunities in Global Fuel Cell Transit and Coach Buses

Future Growth Potential of Fuel Cell Buses Among Fleets will be Influenced by Regional Impetus for Carbon Neutrality

Infographics

×

To meet international climate targets and develop sustainable zero-emission technologies, the mobility industry is expediting the transition to powertrain electrification and gradually reducing dependence on diesel powertrains. In addition to stringent emission norms, subsidies, and tax exemptions, governments are promoting the use of alternative p...

Electrification in trucking is gaining momentum as a Mega Trend, with new mobility models shaping the industry s future. Various sub-trends within electric vehicles (EVs), such as battery EVs (BEVs) and FCEVs, are increasingly popular as emission norms become stricter and the focus on achieving cleaner forms of goods transportation is higher. The p...

16 Nov 2017  |  North America  |  Market Research

Global Executive Analysis of the Fuel Cell Passenger Car Market, Forecast to 2030

Fuel Cell Technology Development and Optimisation to be Heavily Driven by Incentives and Investments

Infographics

×

Research Scope: The research focuses on the legislative measures that have been taken by the Government globally to implement and adopt fuel cell vehicles and bring in new business models for private and public sectors to develop the hydrogen fuel stations across the world. Private and public sectors have constantly provided investments and funding...

07 Feb 2024  |  North America  |  Market Research

Global Manufacturing Execution Systems Growth Opportunities

Disruptive Technologies and New Business Models are Transforming the Industrial Automation Landscape

Infographics

×

The evolution of different kinds of industrial software is leading to the expansion of their functionalities, blurring the lines that make them distinct. The race towards higher levels of automation demands vendors and manufacturers be aware of emerging trends and market dynamics to remain competitive. This report delves into the basic functions of...

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects. ...